Bank of New York Mellon
LOGC

Bank of New York Mellon’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,930
Closed -$3K 4606
2022
Q3
$3K Hold
10,930
﹤0.01% 4543
2022
Q2
$4K Hold
10,930
﹤0.01% 4575
2022
Q1
$7K Hold
10,930
﹤0.01% 4649
2021
Q4
$25K Hold
10,930
﹤0.01% 4573
2021
Q3
$50K Hold
10,930
﹤0.01% 4431
2021
Q2
$49K Sell
10,930
-43,068
-80% -$193K ﹤0.01% 4323
2021
Q1
$394K Sell
53,998
-1,829
-3% -$13.3K ﹤0.01% 3810
2020
Q4
$427K Buy
55,827
+26,633
+91% +$204K ﹤0.01% 3692
2020
Q3
$265K Buy
29,194
+239
+0.8% +$2.17K ﹤0.01% 3764
2020
Q2
$245K Buy
28,955
+8,103
+39% +$68.6K ﹤0.01% 3745
2020
Q1
$103K Hold
20,852
﹤0.01% 3850
2019
Q4
$151K Hold
20,852
﹤0.01% 3961
2019
Q3
$225K Sell
20,852
-1,887
-8% -$20.4K ﹤0.01% 3869
2019
Q2
$295K Sell
22,739
-222
-1% -$2.88K ﹤0.01% 3808
2019
Q1
$227K Buy
+22,961
New +$227K ﹤0.01% 3837